ACE BioSciences Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

ACE BioSciences General Information

Description

Developer of antibacterial drugs. The company is focused on developing novel vaccines for the prevention and treatment of bacterial infections, diarrhea, pneumococcal infections, cancer and streptococcus pneumonia..

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Unsbjergvej 2A
  • 5220 Odense
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ACE BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Nov-2009 000.00 Completed Generating Revenue
2. Later Stage VC 19-Dec-2007 000.00 000.00 Completed Generating Revenue
1. Early Stage VC $33.7M $33.7M Completed Startup
To view ACE BioSciences’s complete valuation and funding history, request access »

ACE BioSciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BankInvest Biotech Ventures Venture Capital Minority 000 0000 000000 0
Dansk Erhvervsinvestering Venture Capital Minority 000 0000 000000 0
Heartcore Capital Venture Capital Minority 000 0000 000000 0
To view ACE BioSciences’s complete investors history, request access »